Cobalt are currently contributing to more than 30 research projects
We are currently contributing to research projects.
We have a dedicated Research Group led by Professor Iain Lyburn and a Research Committee whose members include several highly regarded clinicians working within the research fields of dementia and oncology. The committee meets regularly to review the current projects, as well as consider any other innovations or new exciting projects which may have been presented to us. Most recently this has resulted in a very important project, (our first ever research project involving ultrasound imaging) which is looking into the treatment of cancer patients that are at high risk of developing venous thromboembolism (blood clots).
We also have an exciting joint venture with the 2gether NHS Foundation Trust to develop dementia research. In addition to funding specialist scans utilising state-of-the-art equipment for patients with Young Onset Dementia, we are also funding two dementia research nurses to recruit patients into clinical trials.
We have developed a new research MRI facility on the campus of the Queen Elizabeth Hospital in Birmingham. This new imaging centre will support the Institute of Translational Medicine with numerous research studies, working with Birmingham Health Partners, a partnership between University Hospitals Birmingham NHS Foundation Trust, the University of Birmingham and Birmingham Children’s Hospital NHS Trust.
We are an important centre for cancer research and are currently contributing PET/CT and MRI imaging services for 16 different oncology studies, including several national and international projects. These cover areas such as Lymphoma, Oesophageal cancer, Myeloma and Lung cancer.
Many of these projects are involved in studying the effects of current treatments for cancer or establishing the efficacy of new and novel cancer drug treatments. All of which have the potential to make effective contributions in providing measurable differences in the management and treatment of these illnesses which could, in turn, provide real benefits to patients both in the short and long term.
All of our dementia and oncology projects contribute to our overarching research strategy of further developing our highly regarded, research-active, organisation. This encourages interdisciplinary working between researchers and staff both within and beyond Cobalt, across the whole health community with industry and with potential academic partners, for the benefit of our patients.
Cobalt Continues to Put Research at the Core of Who We Are
A dedicated Research Committee meets quarterly to review our current research and discuss upcoming projects and innovations. The Committee considers how we can support research and contribute to advancing medical practice at Cobalt and in our community.
Research Active Team
Cobalt’s multidisciplinary research team, led by Medical Director Professor Iain Lyburn, work collaboratively on clinically impactful research (see Publications). The team’s commitment to producing novel research has developed relationships with external research teams. This has led to an exciting collaboration with industry partners evaluating the role of artificial intelligence in Positron Emission Tomography/Computerised Tomography (PET/CT).
Clinical Research trials
Cobalt continues to support clinical research trials by providing imaging in Computerised Tomography (CT), Magnetic Resonance Imaging (MRI) and PET/CT. These trials test the safety and effectiveness of drugs, usually compared to a placebo or to the current standard drug. We scan trial participants, often regularly, to evaluate the response to these drugs.
We currently provide imaging for 30 trials, including trials for dementia and oncology.
Cobalt’s ongoing collaboration with The Institute for Translational Medicine, Birmingham
Cobalt will celebrate 5 years of collaboration this year at the Institute for Translational Medicine (ITM). A dedicated research imaging centre located on the campus of the Queen Elizabeth Hospital, Birmingham, next to the ITM, currently provides ongoing imaging for 18 clinical trials, supporting research in neurology, cardiology, oncology, liver and Covid-19.
For more information on the ITM: https://www.itmbirmingham.co.uk
Interested in taking part in research?
Taking part in research helps advance medicine, find better ways to diagnose and treat conditions, and can help to find cures. Are you interested in finding out more or taking part in research? The National Institute for Health Research has created a guide on how to take part in research: https://www.nihr.ac.uk/patients-carers-and-the-public/i-want-to-take-part-in-a-study.htm